GI Innovation
Seoul
About GI Innovation
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $227.3M
- Funding stage: IPO
- Last round: Series C (Jun 2021)
- Ticker: kosdaq:358570
- Website: gi-innovation.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/gi-innovation-83718 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.